PMID- 10409727 OWN - NLM STAT- MEDLINE DCOM- 19990819 LR - 20190508 IS - 0270-7306 (Print) IS - 0270-7306 (Linking) VI - 19 IP - 8 DP - 1999 Aug TI - Purification and identification of p68 RNA helicase acting as a transcriptional coactivator specific for the activation function 1 of human estrogen receptor alpha. PG - 5363-72 AB - The estrogen receptor (ER) regulates the expression of target genes in a ligand-dependent manner. The ligand-dependent activation function AF-2 of the ER is located in the ligand binding domain (LBD), while the N-terminal A/B domain (AF-1) functions in a ligand-independent manner when isolated from the LBD. AF-1 and AF-2 exhibit cell type and promoter context specificity. Furthermore, the AF-1 activity of the human ERalpha (hERalpha) is enhanced through phosphorylation of the Ser(118) residue by mitogen-activated protein kinase (MAPK). From MCF-7 cells, we purified and cloned a 68-kDa protein (p68) which interacted with the A/B domain but not with the LBD of hERalpha. Phosphorylation of hERalpha Ser(118) potentiated the interaction with p68. We demonstrate that p68 enhanced the activity of AF-1 but not AF-2 and the estrogen-induced as well as the anti-estrogen-induced transcriptional activity of the full-length ERalpha in a cell-type-specific manner. However, it did not potentiate AF-1 or AF-2 of ERbeta, androgen receptor, retinoic acid receptor alpha, or mineralocorticoid receptor. We also show that the RNA helicase activity previously ascribed to p68 is dispensable for the ERalpha AF-1 coactivator activity and that p68 binds to CBP in vitro. Furthermore, the interaction region for p68 in the ERalpha A/B domain was essential for the full activity of hERalpha AF-1. Taken together, these findings show that p68 acts as a coactivator specific for the ERalpha AF-1 and strongly suggest that the interaction between p68 and the hERalpha A/B domain is regulated by MAPK-induced phosphorylation of Ser(118). FAU - Endoh, H AU - Endoh H AD - Molecular Medicine Laboratories, Institute for Drug Discovery Research, Yamanouchi Pharmaceutical, Tsukuba, Ibaraki 305-8585, Japan. FAU - Maruyama, K AU - Maruyama K FAU - Masuhiro, Y AU - Masuhiro Y FAU - Kobayashi, Y AU - Kobayashi Y FAU - Goto, M AU - Goto M FAU - Tai, H AU - Tai H FAU - Yanagisawa, J AU - Yanagisawa J FAU - Metzger, D AU - Metzger D FAU - Hashimoto, S AU - Hashimoto S FAU - Kato, S AU - Kato S LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Retracted Publication PL - United States TA - Mol Cell Biol JT - Molecular and cellular biology JID - 8109087 RN - 0 (Estrogen Receptor alpha) RN - 0 (Neoplasm Proteins) RN - 0 (Receptors, Estrogen) RN - 0 (Recombinant Fusion Proteins) RN - EC 2.7.- (Protein Kinases) RN - EC 2.7.11.17 (Calcium-Calmodulin-Dependent Protein Kinases) RN - EC 3.6.1.- (Ddx5 protein, human) RN - EC 3.6.4.13 (DEAD-box RNA Helicases) RN - EC 3.6.4.13 (RNA Helicases) SB - IM RIN - Mol Cell Biol. 2014 Mar;34(5):915. PMID: 24509260 MH - Adenocarcinoma/pathology MH - Amino Acid Sequence MH - Animals MH - Breast Neoplasms/pathology MH - Calcium-Calmodulin-Dependent Protein Kinases/physiology MH - DEAD-box RNA Helicases MH - Estrogen Receptor alpha MH - Female MH - *Gene Expression Regulation MH - Humans MH - Molecular Sequence Data MH - Neoplasm Proteins/isolation & purification/physiology MH - Phosphorylation MH - Protein Binding MH - *Protein Kinases MH - Protein Processing, Post-Translational MH - *Protein Structure, Tertiary MH - RNA Helicases/*isolation & purification/physiology MH - Rabbits MH - Receptors, Estrogen/chemistry/*physiology MH - Recombinant Fusion Proteins/physiology MH - Sequence Analysis MH - *Transcription, Genetic MH - Tumor Cells, Cultured PMC - PMC84379 EDAT- 1999/07/20 00:00 MHDA- 1999/07/20 00:01 CRDT- 1999/07/20 00:00 PHST- 1999/07/20 00:00 [pubmed] PHST- 1999/07/20 00:01 [medline] PHST- 1999/07/20 00:00 [entrez] AID - 10.1128/mcb.19.8.5363 [doi] PST - ppublish SO - Mol Cell Biol. 1999 Aug;19(8):5363-72. doi: 10.1128/mcb.19.8.5363.